Rury R. Holman
0000-0002-1256-874X
Publication & Citation Trends
Publications
0 total
Validation of a treatment selection algorithm for optimal choice of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups
Cited by 0
Semantic Scholar
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis. OA
Cited by 8
Semantic Scholar
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study. OA
Cited by 23
Semantic Scholar
Leveraging External Controls in Clinical Trials: Estimands, Estimation, Assumptions
Cited by 0
Semantic Scholar
The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture.
Cited by 0
Semantic Scholar
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy
Cited by 0
Semantic Scholar
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Cited by 1
Semantic Scholar
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Cited by 0
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(267)
Diabetes, Cardiovascular Risks, and Lipoproteins
(151)
Diabetes Management and Research
(141)
Metabolism, Diabetes, and Cancer
(74)
Cardiovascular Function and Risk Factors
(48)
Affiliations
University of Foggia
University of North Carolina at Chapel Hill
Turing Institute
Oslo University Hospital
Indiana University Health